Advocates For Oral Contraceptive Switch Shop For Pharma Partner
This article was originally published in The Tan Sheet
A Center for Reproductive Rights report acknowledges work by the Oral Contraceptives Over-the-Counter Working Group, which is positioned to partner on a switch NDA through a $12m grant, and looks comprehensively at the outlook for a daily-use oral contraceptive switch.
You may also be interested in...
A new paradigm for nonprescription approvals could eliminate the risk of self-selecting a birth control drug, with some contraindications might likely not apparent, by having pharmacists provide counseling and screening or having women use a self-assessment tool with a standard algorithm.
Bayer notes “significant headwinds" from pandemic hitting its 2020 results likely will continue in 2021, when it t expects core earnings per share slightly below 2020 levels. While noting slumping revenues across its divisions, Bayer said an exception its consumer health business.
Senate on 29 September was expected to a pass a CR the House passed a week earlier to fund FDA and other federal departments and agencies through 11 December.